| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |